This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Axis Capital (AXS) Loses 6.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Axis Capital (AXS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Axis Capital (AXS) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Axis Capital (AXS) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Axis Capital (AXS) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Axis Capital (AXS) delivered earnings and revenue surprises of +19.49% and +0.71%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for These 3 Insurance Stocks in Q3 Earnings?
by Sushmita Sarker
Here, we take a look at three insurance stocks, PRU, AXS, and EG, which are set to report third-quarter earnings on Oct. 29.
AXS or CINF: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AXS vs. CINF: Which Stock Is the Better Value Option?
CNA Financial (CNA) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
CNA Financial (CNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights Travelers, Allstate, Cincinnati Financial, CNA Financial and Axis Capital
by Zacks Equity Research
Travelers, Allstate, Cincinnati Financial, CNA Financial and Axis Capital stand out as Zacks sees strong growth ahead for the P&C insurance industry.
5 Stocks to Add to Your Portfolio From the Prospering P&C Insurance Industry
by Tanuka De
Zacks Property and Casualty Insurance players like TRV, ALL, CINF, CNA and AXS are likely to benefit from digitization and catastrophes that drive policy renewal rate and pricing.
Implied Volatility Surging for AXIS Capital Stock Options
by Zacks Equity Research
Investors need to pay close attention to AXS stock based on the movements in the options market lately.
Axis Capital (AXS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Axis Capital (AXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AXS or CINF: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
AXS vs. CINF: Which Stock Is the Better Value Option?
Axis Capital (AXS) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Axis Capital (AXS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
AXS Outperforms Industry, Trades at a Discount: How to Play the Stock
by Zacks Equity Research
AXIS Capital gains from a well-performing specialty insurance, reinsurance, as well as the accident and health portfolio.
Selective Insurance to Benefit From Growing Premium Amid Cost Woes
by Zacks Equity Research
SIGI stock remains poised to gain from solid retention rates, higher new business gains and renewal pure price increases.
3 P&C Insurance Stocks That Have Outperformed the S&P 500 in a Year
by Sushmita Sarker
Given the prospects of the Property and Casualty Insurance industry, PLMR, WRB and AXS have the potential to generate better returns than other players.
AXS Outperforms Industry, Trades Near 52-Week High: Time to Hold?
by Zacks Equity Research
AXIS Capital gains from a well-performing specialty insurance, reinsurance, as well as the accident and health portfolio.
Why Is Axis Capital (AXS) Up 5% Since Last Earnings Report?
by Zacks Equity Research
Axis Capital (AXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FAF Stock Near 52-Week High: A Signal for Investors to Hold Tight?
by Zacks Equity Research
First American is set to gain from investments in technology, expanding valuation and data businesses and effective capital deployment.
Selective Insurance Set to Grow on Rising Premium Amid Challenges
by Zacks Equity Research
Selective Insurance targets growth with rising premiums, strong Commercial Lines and geographic expansion despite industry headwinds.
American Financial Banks on Renewal Pricing Amid Cost Woes
by Zacks Equity Research
AFG stock gains from new business opportunities, increased exposures, a better renewal rate environment, and effective capital deployment.
Is the Options Market Predicting a Spike in Axis Capital Stock?
by Zacks Equity Research
Investors need to pay close attention to Axis Capital stock based on the movements in the options market lately.
AIG Q2 Earnings Beat on Higher North America Commercial Premiums
by Zacks Equity Research
American International posts a 56% year-over-year jump in Q2 earnings, driven by higher North America Commercial and International Commercial premiums, strong investment income and lower expenses.
Aflac Q2 Earnings Beat Estimates on Solid Cancer Product Sales
by Zacks Equity Research
AFL's Q2 earnings benefit from robust Japan cancer insurance sales and strong persistency rates in the U.S. business, partly offset by rising costs.
Berkshire Hathaway Q2 Earnings & Revenues Decline Year Over Year
by Zacks Equity Research
BRK.B Q2 results reflect lower earnings in insurance underwriting, lower sales and service revenues, offset by higher insurance premiums earned.
CNO Q2 Earnings Beat Estimates on Strong Annuity Collected Premiums
by Zacks Equity Research
CNO Financial's Q2 earnings benefit from growth in annuity and health premiums, and rising fee income, partly offset by an elevated expense level. It still expects 2025 operating EPS within $3.70-$3.90.